It is important to note that the active groups in the FAD, NADPH, and FMN structures are the orthophosphoric groups
Lotte Bjerre Knudsen, a Novo Nordisk researcher, saw that data and thought that GLP-1 looked like it turned off appetite just as well as it could crank up insulin secretion
Still, as more entrants bring new GLP-1 or multi-agonist drugs to market, the competitive pressure is likely to increase potentially improving affordability and access for a broader patient population
Overall, while GLP-1 receptor agonists like Ozempic hold promise for improving metabolic health, their impact on the gut microbiota underscores the need for further research into the complex interplay between pharmaceutical interventions, gut microbiome dynamics, and overall health outcomes
Bioactive compounds in garlic
Originally developed under the brand name Ozempic for type 2 diabetes, it later received FDA approval as Wegovy at a higher dose specifically for chronic weight management